Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

The role of medical affairs (MA) and disease-state education has become essential in advancing patient care and supporting ...

PMEA returned on 21 November at the Sheraton Grand in London to recognise excellence within pharmaceutical marketing. The ...

What makes a story powerful? Storytelling is becoming more critical than ever. In medical publications, healthcare providers ...

Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its ...

Merck & Co – known as MSD outside the US and Canada – has entered into an exclusive global licensing agreement worth over ...

The European Academy of Allergy and Clinical Immunology (EAACI) has launched the first World Anaphylaxis Awareness Day today ...

But as AI has become more prevalent, we have started to recognise the advantages and opportunities it offers through a ...

New Environmental, Social and Governance (ESG) regulations coming into force across the EU in 2025 stand to shift how ...

The European Medicines Group (EMG) has appointed Sanofi’s Rippon Ubhi as its new chair. Ubhi, who will maintain her position ...

Medical Writer, Steph Gathercole, looks at the impact increased access to online health information has on the public through ...

Merck KGaA and Abbisko Therapeutics have announced positive results from a late-stage study of pimicotinib in patients with ...